2mg
This product is for research purposes only. Not for human consumption.
Purity: >98% (HPLC verified)
Formulation: Lyophilized powder
Molecular Formula: C55H75N17O13
Molecular Weight: 1182.3 g/mol
CAS Number: 33515-09-2
PubChem CID: 638678

Gonadorelin
Overview
Gonadorelin is a synthetic decapeptide (pyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) with a sequence identical to the naturally occurring gonadotropin-releasing hormone (GnRH), also known as luteinizing hormone-releasing hormone (LHRH). GnRH is a key hormone produced in the hypothalamus that regulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland.
Mechanism of Action
Gonadorelin acts by binding to GnRH receptors (GnRHR) on gonadotroph cells in the anterior pituitary gland. These are G-protein coupled receptors that, upon activation, initiate intracellular signaling pathways that regulate gonadotropin synthesis and secretion.
Receptor Signaling Cascade
Upon binding its receptor, gonadorelin primarily activates the Gq/11 protein pathway. This leads to the activation of phospholipase C (PLC), which hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 can trigger calcium release from intracellular stores, and DAG activates protein kinase C (PKC).
These signaling events are involved in the exocytosis of LH and FSH granules and the transcription of gonadotropin subunit genes.
Pattern-Dependent Response
The cellular response to gonadorelin is highly dependent on the pattern of receptor exposure. Pulsatile exposure, mimicking endogenous GnRH secretion patterns, has been observed to sustain gonadotropin release. In contrast, continuous exposure can lead to GnRH receptor downregulation, internalization, and desensitization, resulting in the suppression of LH and FSH secretion.
This paradoxical effect is a key area of study for long-acting GnRH agonists, which are distinct chemical entities.
Downstream Effects
The released gonadotropins act on the gonads. LH stimulates testosterone production in testicular Leydig cells and progesterone production in ovarian theca cells. FSH supports spermatogenesis and follicular development. This system is known as the hypothalamic-pituitary-gonadal axis.
Research Findings
Published nonclinical literature relevant to this material's molecular targets and experimental models is listed below for independent review. Findings involving other preparations or experimental systems should not be attributed to this research material.
Research Applications
- GnRH receptor pharmacology
- Pituitary function assessment
- Hypothalamic-pituitary-gonadal axis studies
- Hypogonadotropic hypogonadism models
- Ovulation induction research
- Neuroendocrine feedback systems
- Reproductive endocrinology research
Laboratory Handling & Limitations
This material is supplied solely for in vitro and other nonclinical laboratory research. It is not for human or veterinary use, consumption, administration, therapeutic use, or diagnostic use.
Laboratory Handling
Handle only in an appropriately equipped laboratory using applicable institutional procedures, personal protective equipment, and the storage conditions shown for the material. The purchaser is responsible for study design, handling controls, disposal, and regulatory compliance.
Research Limitations
Published observations involving other preparations, experimental systems, or study populations do not establish the identity, performance, or suitability of this research material for any particular experiment.
Scientific References
Research Use Only
This product is intended for research purposes only and is not for human consumption, therapeutic use, or diagnostic applications. Please ensure compliance with all applicable regulations and institutional guidelines.